Skip to content
Indian snakeroot (Rauvolfia serpentina)

Apocynaceae · root

Indian snakeroot

Rauvolfia serpentina

Human clinical trialsRestricted / professional onlyToxicity warning

The plant that became a drug (reserpine). In this catalog as a toxicity-adjacent restricted entry next to hypertension mappings.

Safety first

Reserpine source. Historical antihypertensive. Depression, Parkinsonism, nasal congestion, and peptic-ulcer cautions. Professional only — listed so nobody forages it as a blood-pressure tea.

This entry exists so you do not use the plant casually. It is not a treatment suggestion.

Tradition vs trials

Traditional record. Ayurvedic sarpagandha. 20th-century Western medicine isolated reserpine; the drug, not the root tea, is the historical object.

Trial literature. Reserpine has human antihypertensive data and a psychiatric adverse-effect file. Unstandardized root is not that tablet.

Practical ranges

Educational ranges — not a prescription. Culinary use is not an extract.

  • root

    This catalog will not present a DIY hypotensive range

    WHO monographs / historical reserpine labelsEducational range only — not a prescription. A licensed clinician individualizes product, dose, and duration.

Pregnancy, nursing, children

  • Pregnancy. Avoid.
  • Nursing. Avoid (alkaloids).
  • Children. Not a pediatric plant.

Contraindications

  • depression
  • Parkinsonism
  • unsupervised blood-pressure use
  • active peptic ulcer in classical reserpine cautions

Key interactions

  • MAOIs / other antihypertensives / levodopa · avoid

    Depression, hypotension, and Parkinson-drug disruption.

Open drug–herb checker